- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02615171
RELAX: A Mobile Application Suite Targeting Obesity and Stress
Study Overview
Status
Detailed Description
Obesity and stress are highly comorbid and both increase risk for cardiovascular disease (CVD). Stress is associated with disinhibited eating, junk food consumption and low consumption of produce and whole grains. Both stress and stress-induced eating are not only associated with obesity but also predict worst outcomes in lifestyle interventions. Stress and stress-induced eating should be targeted in interventions to maximize weight loss; however, this makes for a very intensive intervention. Technology could be leveraged to reduce intervention burden.
In this trial investigators propose to compare the feasibility, usability, acceptability, and burden of an traditional weight loss app that includes diet and physical activity self-monitoring features to an app (Slip Buddy) we developed that focuses on self-monitoring of stress eating. With Slip Buddy, the user is just asked to track overeating episodes, indicating when they are triggered by stress. The majority of weight loss apps are burdensome to users by requiring them to self-monitor diet and exercise. They also ignore major barriers to weight loss, such as stress. This work moves the field forward by addressing user burden and an important barrier to weight loss.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Storrs, Connecticut, United States, 06269
- University of Connecticut
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have a BMI of 27-45
- Currently use an Android smartphone
- Have cell phone connectivity at home and work
- Uses a smartphone every day
Exclusion Criteria:
- Under the age of 18 and over the age of 65;
- BMI under 27 or over 45;
- Not interested in losing weight;
- Does not currently own a smartphone;
- Smartphone type and/or version not meeting app requirements;
- No phone connectivity at home and work;
- Unable to walk unaided for ¼ mile without stopping;
- Has a condition that precludes dietary changes (i.e. ulcerative colitis, Crohn's disease, active diverticulitis, renal disease);
- On a medication affecting weight;
- Type 1 or 2 diabetes;
- Had gastric bypass surgery;
- Had or plans to have gastric bypass surgery during the study period;
- Pregnant/lactating;
- Has bipolar disorder, substance abuse, bulimia, or severe depression;
- Lost 5% or more body weight in the last 3 months;
- Has not experienced emotional eating over the last week;
- On medication affecting weight;
- Has concerns about being audiotaped;
- Prisoner;
- Unable to provide consent; or
- Non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Comprehensive Dietary Self-Monitoring
The intervention includes Facebook-delivered weight loss counseling and the use of MyFitnessPal, a comprehensive diet and exercise self-monitoring app.
The intervention will last for 12 weeks.
In addition to weight loss counseling in a private Facebook group, participants will be encouraged to use the self-monitoring app to enter everything they eat and do for exercise during the intervention period (12 weeks).
Participants will receive a daily calorie goal directly from the app.
Participants will receive a Fitbit scale to take their weight weekly and at assessments.
|
The intervention includes Facebook-delivered weight loss counseling and the use of MyFitnessPal, a comprehensive diet and exercise self-monitoring app.
The intervention will last for 12 weeks.
In addition to weight loss counseling in a private Facebook group, participants will be encouraged to use the self-monitoring app to enter everything they eat and do for exercise during the intervention period (12 weeks).
Participants will receive a daily calorie goal directly from the app.
Participants will receive a Fitbit scale to take their weight weekly and at assessments.
|
Active Comparator: Simple Dietary Self-Monitoring
The intervention includes Facebook-delivered weight loss counseling and the use of Slip Buddy, an app created by the investigative team that only requires users to record instances of overeating by hitting a single button and then indicate the overeating trigger and stress and hunger levels.
The intervention will last for 12 weeks.
In addition to the weight loss counseling, participants will be asked to use the Slip Buddy app during the intervention period (12 weeks).
Participants will receive a Fitbit scale to take their weight weekly and at assessments.
|
Arm: Active Comparator: Simple Dietary Self-Monitoring he intervention includes Facebook-delivered weight loss counseling and the use of Slip Buddy, an app created by the investigative team that only requires users to record instances of overeating by hitting a single button and then indicate the overeating trigger and stress and hunger levels.
The intervention will last for 12 weeks.
In addition to the weight loss counseling, participants will be asked to use the Slip Buddy app during the intervention period (12 weeks).
Participants will receive a Fitbit scale to take their weight weekly and at assessments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Days App Used Over 12 Weeks
Time Frame: 12 weeks
|
App use was measured for each condition using either backend data from Slip Buddy or reviewing MyFitnessPal entries indicating use over each 24-hour period.
|
12 weeks
|
Usability
Time Frame: 12 weeks
|
Usability will be assessed using the System Usability Scale (SUS), a 10-item measure with 5-point Likert scale response options (Strongly Agree to Strongly Disagree).
Scores are summed (0-40) then converted to a 0-100 scale, with higher scores indicating higher usability.
Scores above 58 are considered above average, and scores above 80 are considered to indicate high usability where participants are likely to recommend the product to friends.
|
12 weeks
|
Acceptability
Time Frame: 12 weeks
|
Acceptability was assessed with a single item at 12 weeks assessing perceived helpfulness of the assigned app: "Tracking my diet and exercise with MFP/slips with Slip Buddy was helpful" (responses on a 5-point Likert scale from strongly disagree to strongly agree).
Acceptability was indicated by responses of agree or strongly agree.
|
12 weeks
|
Burden
Time Frame: 12 weeks
|
At 12 weeks, participants were asked how burdensome the task of using their assigned application was on a scale of 0-100, 0 being not at all burdensome and 100 being very burdensome.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent Weight Change From Baseline to 12-Week Follow-Up
Time Frame: 12 weeks
|
A digital scale (Fitbit Aria) will be used to record weight.
Percent weight change was calculated using weight at baseline and weight at 12-week follow-up.
Missing values were calculated using last carry forward (LOCF).
|
12 weeks
|
Change in Perceived Stress From Baseline to 12-Week Follow-Up
Time Frame: 12 weeks
|
The Perceived Stress Scale is a 14-item measure of perceived stress.
Scores range from 0-56, higher scores indicate higher perceived stress.
|
12 weeks
|
Change in Emotional Eating From Baseline to 12-Week Follow-Up
Time Frame: 12 weeks
|
Three-Factory Eating Inventory is an 18-item measure and the emotional eating subscale consists of 3 items on a 4-point Likert scale.
The score is derived by a multi-step equation.
The range of scores for this subscale is 0-100, higher scores indicate higher emotional eating.
|
12 weeks
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H17-217
- 1R01HL122302-01A1 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdNot yet recruitingStress | Mood | Physiological Stress
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Comprehensive Dietary Self-Monitoring; Device: smartphone; Other: physical activity
-
University of PennsylvaniaCompletedObesity | Liver Transplant; Complications | Kidney Transplant; ComplicationsUnited States
-
University of South CarolinaUniversity of Colorado, Denver; Brown University; InquisitHealth, Inc.Active, not recruiting
-
University of Southern CaliforniaCompletedNeurological DisorderUnited States
-
Queen's University, BelfastCompleted
-
Danube University KremsUniversity of Vienna; University of InnsbruckRecruiting
-
Joslin Diabetes CenterDHR Health Institute for Research and Development; Verizon FoundationCompletedType 2 Diabetes MellitusUnited States
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Abbott...Completed
-
Northwell HealthNational Institute on Aging (NIA)Not yet recruitingType 2 DiabetesUnited States
-
University of TennesseeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedObesity | OverweightUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States